REITHERA

🚨 Only 5 days left until ESGCT 2024 kicks off! 🚨 Are you looking to boost 𝗔𝗔𝗩 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝘃𝗶𝘁𝘆? Join us for an exciting presentation about the collaboration between ReiThera and Virica Biotech to discover how our partnership is revolutionizing AAV production with enhanced yields across multiple serotypes. 🌟 When: 𝗧𝗵𝘂𝗿𝘀𝗱𝗮𝘆 𝟮𝟰𝘁𝗵,𝟭𝟭 𝗔𝗠 🌟 Where: 𝗕𝗼𝗼𝘁𝗵 𝗕𝟭𝟰/𝟭𝟲 📊 𝗖𝗵𝗲𝗰𝗸 𝗼𝘂𝘁 𝘁𝗵𝗲 𝗱𝗮𝘁𝗮 𝗮𝗻𝗱 𝗹𝗲𝘁’𝘀 𝗱𝗶𝘀𝗰𝘂𝘀𝘀 𝗵𝗼𝘄 𝘄𝗲 𝗰𝗮𝗻 𝘁𝗮𝗸𝗲 𝘆𝗼𝘂𝗿 𝗔𝗔𝗩 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻 𝘁𝗼 𝘁𝗵𝗲 𝗻𝗲𝘅𝘁 𝗹𝗲𝘃𝗲𝗹! 💬 For more information, feel free to reach out: abenson@viricabiotech.com claudio.panzarella@reithera.com Don't miss it! We can’t wait to see you at ESGCT 2024! 🎉 #ESGCT2024 #AAVProduction #BiotechInnovation #GeneTherapy #ViralVectors #ReiThera #Virica #Partnership

🚀 𝗖𝗼𝘂𝗻𝘁𝗱𝗼𝘄𝗻 𝘁𝗼 𝗘𝗦𝗚𝗖𝗧 𝟮𝟬𝟮𝟰: 𝗢𝗻𝗹𝘆 𝟲 𝗱𝗮𝘆𝘀 𝘁𝗼 𝗴𝗼! 🧬 We’re excited to showcase some groundbreaking research at ReiThera during ESGCT 2024! Here’s what to expect from 2 of our 8 presentations: 🔬 𝗚𝗥𝗔𝗱 𝗮𝘀 𝗮 𝘃𝗮𝗰𝗰𝗶𝗻𝗲 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺 𝗳𝗼𝗿 𝗖𝗢𝗩𝗜𝗗-𝟭𝟵, 𝗛𝗜𝗩, 𝗮𝗻𝗱 𝗴𝗹𝗼𝗯𝗮𝗹 𝗵𝗲𝗮𝗹𝘁𝗵 🗓️ When? Wed. 23rd | 8:30-10:30 📍 Where? SESSION 3c: Infectious Diseases / Vaccines Presented by Angelo Raggioli, PhD 🔧 𝗢𝗽𝘁𝗶𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝘁𝗵𝗲 𝘁𝘄𝗼-𝗽𝗹𝗮𝘀𝗺𝗶𝗱 𝘀𝘆𝘀𝘁𝗲𝗺 𝗳𝗼𝗿 𝗔𝗔𝗩 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻 🗓️ When? Wed. 23rd | 13:30-14:30 📍 Where? LUNCHTIME SYMPOSIUM: PlasmidFactory Featuring a spotlight on plasmid and minicircle DNA starting materials for AAV vectors Presented by Michela Gentile, PhD These sessions will highlight important innovations in vaccine platforms and AAV production—don’t miss it! We look forward to discussing our latest advancements in gene therapy and biomanufacturing. For more information or to connect with our team: ✉️ claudio.panzarella@reithera.com ✉️ businessdevelopment@reithera.com #ESGCT2024 #GeneTherapy #Vaccines #COVID19 #HIV #AAV #ReiThera #PlasmidFactory #Innovation #Biotechnology #GlobalHealth

🚀 Exciting Times Ahead! 🚀 In just 𝟳 𝗱𝗮𝘆𝘀, the #ESGCT2024 (European Society of Gene & Cell Therapy) conference will kick off, and we are thrilled to announce that ReiThera will be there! As a company deeply committed to advancing innovation in #GeneTherapy and #CellTherapy, ESGCT is the perfect platform for us to engage with the brightest minds and share our latest advancements. Come meet us at 𝗕𝗼𝗼𝘁𝗵 𝗕𝟭𝟰/𝟭𝟲 or contact us at 𝗯𝘂𝘀𝗶𝗻𝗲𝘀𝘀𝗱𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁@𝗿𝗲𝗶𝘁𝗵𝗲𝗿𝗮.𝗰𝗼𝗺 Join us to explore how we're shaping the future of medical science and contributing to a healthier, safer world. 🌍💉 Stay tuned for more updates, and see you at ESGCT 2024! #Biotech #ESGCT2024 #ReiThera #CellTherapy #GeneTherapy #Innovation #Healthcare #Science

We at ReiThera are proud to support the Sabin Vaccine Institute in delivering an additional 1,000 doses of investigational vaccines to Rwanda, as part of the ongoing fight against the Marburg virus outbreak declared on September 27. This shipment builds on the initial 700 doses sent last weekend, marking a critical step in reinforcing the response efforts. In an outbreak, speed is everything. Our experience in managing vaccine logistics, combined with close collaboration with the Rwandan government and Sabin, enabled us to prepare and ship the doses efficiently. Together, we are working to help end this outbreak as swiftly as possible. #PublicHealth #MarburgVirus #VaccineLogistics #GlobalHealth #ReiThera #SabinVaccineInstitute

Stiamo #assumendo per un ruolo di “HEAD OF PROCESS DEVELOPMENT” a Greater Rome Metropolitan Area. Candidati subito o condividi questo post con la tua rete.

 🚀 We are incredibly proud to announce that ReiThera has successfully manufactured and shipped doses of the Marburg disease vaccine to Rwanda! 🎉 This milestone marks a crucial step forward in the global fight against this dangerous virus, and we couldn't be prouder of the impact this will have on public health. 🤝 “At ReiThera, we believe in the transformative power of global collaboration to advance science and create lasting impact. Our partnership with Sabin highlights our shared commitment to developing a life-saving vaccine against Marburg disease with a mutual goal: to save lives and ensure that even the most vulnerable communities around the world have access to vital and equitable protection” says Stefano Colloca, CEO of Reithera: “I also want to personally thank our incredible team for their hard work and dedication in successfully manufacturing and shipping the vaccine doses. Your commitment was able to truly make a difference and I couldn't be prouder of what we've achieved together." #Teamwork #ProudCEO #VaccineInnovation #GlobalHealth #ReiThera

I’ve never been more humbled or prouder of the Sabin team. Delivering our #Marburg candidate vaccine to Rwanda within 9 days of the outbreak being declared is an incredible achievement—especially for a small nonprofit like ours. But we didn’t do it alone. We’re deeply grateful to our partners, especially REITHERA, for their support. A huge part of making this possible was the seamless collaboration with the Rwandan government. Their commitment and focus were exemplary, streamlining the process when time was critical. Fortunately, because we’re already conducting Phase 2 trials in Uganda and Kenya, we were able to quickly prepare the paperwork for a new trial. And, importantly, Sabin and ReiThera had vaccine doses ready to go. This remarkable effort truly reflects the power of partnerships and preparedness. More details in our news release: https://lnkd.in/ddBrzXXT

🚀 ReiThera's Manufactured Sudan Ebolavirus Vaccine Reaches Key Milestone 🚀 We’re excited to announce a significant achievement in our ongoing collaboration with the Sabin Vaccine Institute in the fight against life-threatening infectious diseases. A Phase 2 clinical trial for the Sudan ebolavirus vaccine, sponsored by Sabin Vaccine Institute, has now launched in Uganda. Here’s what we’ve accomplished so far: 💉 Manufactured and shipped critical doses of the Sudan ebolavirus vaccine to Uganda. 💪 Since 2019, we’ve developed a cutting-edge production process, increasing productivity by more than 4x, resulting in over 200,000 doses ready for emergency use. 🌍 In 2022, we shipped 1,100 doses, contributing to the containment of a local outbreak. This progress highlights ReiThera’s commitment to rapid vaccine production and global health preparedness. Thank you to our dedicated team and partners for making this possible. Together, we’re ready to tackle future outbreaks. Find the PR at: https://lnkd.in/dMRX3nrE #GlobalHealth #VaccineInnovation #EbolaResponse #PublicHealth #ReiThera #SabinVaccineInstitute #ClinicalTrials

ERDERA opens a new era for rare disease research in Europe and beyond! 🚀 👩🏽🔬Backed by the European Union, over 170 organizations are uniting to make Europe a leader in rare disease research and innovation. At REITHERA, we're proud to partner with the European Rare Disease Research Alliance (ERDERA)! 🌍💙 Read ERDERA’s press release to learn more 🗞️https://bit.ly/3zgaZA0 Visit our website🌐 erdera.org #ERDERA #RareDiseases #ResearchInnovation #HealthInnovation 

🔬 Explore the Future of Gene Therapy Manufacturing! 🚀 Check out the Pharma Almanac roundtable to see how CDMOs are using stable cell lines, advanced purification, and AI-driven innovations to enhance scalability and product purity in gene therapy. Discover how these cutting-edge technologies are shaping the future of bioproduction. https://lnkd.in/eBD8nppK #biotech #genetherapy #biotechnology #gmp #cellandgenetherapy #healthcare #healthtech